MedicalgorithmicsFRA:B8E -3.10%72 Gross Margin % is 88.31% as of Mar. 2026, which is 2% below its 10-year median of 90.30. GuruFocus rates FRA:B8E with a GF Score™ of 72/100 and a GF Value™ of €6.00. The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Medicalgorithmics ranks better than 96.52% on this metric.
The historical rank and industry rank for Medicalgorithmics's Gross Margin % or its related term are showing as below:
FRA:B8E'
s Gross Margin % Range Over the Past 10 Years
Min: 79.49 Med: 90.3 Max: 97.4
Current: 89.56
During the past 13 years, the highestGross Margin % of Medicalgorithmics was 97.40%. The lowest was 79.49%. And the median was 90.30%.
FRA:B8E's Gross Margin % is ranked better than 96.52% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs FRA:B8E: 89.56
Medicalgorithmics had a gross margin of 88.31% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Medicalgorithmics was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Medicalgorithmics had a gross margin of 88.31% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Medicalgorithmics Gross Margin % Related Terms
Medicalgorithmics Gross Margin % Historical Data
* Premium members only.
The historical data trend for Medicalgorithmics's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:B8E vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Medicalgorithmics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicalgorithmics Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Medicalgorithmics's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Medicalgorithmics (FRA:B8E) has a Gross Margin % of 88.31% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Medicalgorithmics and its competitors. This is near median its historical median of 90.30. Over the past decade, Medicalgorithmics' Gross Margin % has ranged from 79.49 to 97.40. According to the industry distribution chart, Medicalgorithmics ranks #28 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 3.5%.
Is Medicalgorithmics' Gross Margin % too high?
Medicalgorithmics' current Gross Margin % of 88.31% is near median its 10-year median of 90.30. Over the past 10 years, this metric has ranged from a low of 79.49 to a high of 97.40. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Medicalgorithmics' value of 88.31% is 69.6% above this industry median. Based on the distribution chart, Medicalgorithmics ranks #28 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medicalgorithmics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medicalgorithmics ranks #28 out of 805 companies for Gross Margin %. This places Medicalgorithmics in the top 4% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. Medicalgorithmics' value of 88.31% is 69.6% above this benchmark. Historically, Medicalgorithmics' own Gross Margin % has ranged from 79.49 to 97.40 over the past decade. While the company's 10-year median is 90.30 vs. the industry median of 52.07, Medicalgorithmics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicalgorithmics's current Gross Margin % of 88.31% is 69.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Medicalgorithmics and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicalgorithmics's current Gross Margin % is 88.31%, which is near median its own 10-year median of 90.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (FRA:B8E) has a current Gross Margin % of 88.31%. The stock's GF Value™ is €6.00, compared to a current price of €5.94 — trading 1% below its estimated fair value. The current Gross Margin % is 88.31%, which is near median its 10-year median of 90.30 and 69.6% above the Medical Devices & Instruments industry median of 52.07. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Medicalgorithmics (FRA:B8E), the current Gross Margin % is 88.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicalgorithmics (FRA:B8E) Overvalued in 2026?
Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued.
The current stock price of €5.94 is trading 1% below its estimated GF Value™ of €6.00.
Key valuation signals for FRA:B8E:
Gross Margin %: 88.31% (near median its 10-year median of 90.30)
GF Value™: €6.00 vs. price of €5.94 (1% below fair value)
Industry Position: 69.6% above the Medical Devices & Instruments median (#28 of 805)
No single metric tells the full story. See the FRA:B8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score
Get the complete analysis for FRA:B8E
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:B8E has been successfully added to your 
